Takeda Pharmaceutical Company Limited Earnings

Takeda Pharmaceutical Company Limited’s revenue jumped 2.96% since last year same period to $1144124Mn in the Q4 2024. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -2.71% fall in its revenue since last 3-months.

Takeda Pharmaceutical Company Limited’s net profit fell -77.5% since last year same period to $23789Mn in the Q4 2024. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -74.16% fall in its net profits since last 3-months.

Takeda Pharmaceutical Company Limited’s net profit margin fell -78.15% since last year same period to 2.08% in the Q4 2024. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -73.43% fall in its net profit margins since last 3-months.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current quarter stand at 0.63 - a -99.28% fall from last quarter’s estimates.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current year stand at 0.63.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) fell -99.86% since last year same period to 0.05 in the Q4 2024. This indicates that the Takeda Pharmaceutical Company Limited has generated -99.86% annual rate of fall in its earning per share (EPS) in the last 4 quarters.